We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ongoing Drug Shortages More Challenging for FDA Than New Ones
Ongoing Drug Shortages More Challenging for FDA Than New Ones
The most challenging drug shortages the U.S. faces are not the new ones that crop up from illnesses like COVID-19 or the current spike in respiratory illnesses. Rather, the shortages that have been ongoing for years cause the FDA the most strife.